1 Market Overview

1.1 Product Overview and Scope of Competent Cells

1.2 Classification of Competent Cells by Type

1.2.1 Overview: Global Competent Cells Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Competent Cells Revenue Market Share by Type in 2021

1.2.3 Chemically Competent Cells

1.2.4 Electrocompetent Cells

1.3 Global Competent Cells Market by Application

1.3.1 Overview: Global Competent Cells Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Subcloning & Routine Cloning

1.3.3 Phage Display Library Construction

1.3.4 Toxic/Unstable DNA Cloning

1.3.5 High-Throughput Cloning

1.3.6 Protein Expression

1.3.7 Mutagenesis

1.3.8 Single-Stranded DNA Production

1.3.9 Bacmid Creation

1.3.10 Cre-Lox Recombination (PIR1/PIR2)

1.4 Global Competent Cells Market Size & Forecast

1.5 Global Competent Cells Market Size and Forecast by Region

1.5.1 Global Competent Cells Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Competent Cells Market Size by Region, (2017-2022)

1.5.3 North America Competent Cells Market Size and Prospect (2017-2028)

1.5.4 Europe Competent Cells Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Competent Cells Market Size and Prospect (2017-2028)

1.5.6 South America Competent Cells Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Competent Cells Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Competent Cells Market Drivers

1.6.2 Competent Cells Market Restraints

1.6.3 Competent Cells Trends Analysis

2 Company Profiles

2.1 Merck KGaA

2.1.1 Merck KGaA Details

2.1.2 Merck KGaA Major Business

2.1.3 Merck KGaA Competent Cells Product and Solutions

2.1.4 Merck KGaA Competent Cells Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Merck KGaA Recent Developments and Future Plans

2.2 Thermo Fisher Scientific

2.2.1 Thermo Fisher Scientific Details

2.2.2 Thermo Fisher Scientific Major Business

2.2.3 Thermo Fisher Scientific Competent Cells Product and Solutions

2.2.4 Thermo Fisher Scientific Competent Cells Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Thermo Fisher Scientific Recent Developments and Future Plans

2.3 Agilent Technologies

2.3.1 Agilent Technologies Details

2.3.2 Agilent Technologies Major Business

2.3.3 Agilent Technologies Competent Cells Product and Solutions

2.3.4 Agilent Technologies Competent Cells Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Agilent Technologies Recent Developments and Future Plans

2.4 Takara Bio

2.4.1 Takara Bio Details

2.4.2 Takara Bio Major Business

2.4.3 Takara Bio Competent Cells Product and Solutions

2.4.4 Takara Bio Competent Cells Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Takara Bio Recent Developments and Future Plans

2.5 Promega Corporation

2.5.1 Promega Corporation Details

2.5.2 Promega Corporation Major Business

2.5.3 Promega Corporation Competent Cells Product and Solutions

2.5.4 Promega Corporation Competent Cells Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Promega Corporation Recent Developments and Future Plans

2.6 Beijing TransGen Biotech

2.6.1 Beijing TransGen Biotech Details

2.6.2 Beijing TransGen Biotech Major Business

2.6.3 Beijing TransGen Biotech Competent Cells Product and Solutions

2.6.4 Beijing TransGen Biotech Competent Cells Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Beijing TransGen Biotech Recent Developments and Future Plans

2.7 GeneScript Corporation

2.7.1 GeneScript Corporation Details

2.7.2 GeneScript Corporation Major Business

2.7.3 GeneScript Corporation Competent Cells Product and Solutions

2.7.4 GeneScript Corporation Competent Cells Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 GeneScript Corporation Recent Developments and Future Plans

2.8 Yeastern Biotech

2.8.1 Yeastern Biotech Details

2.8.2 Yeastern Biotech Major Business

2.8.3 Yeastern Biotech Competent Cells Product and Solutions

2.8.4 Yeastern Biotech Competent Cells Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Yeastern Biotech Recent Developments and Future Plans

2.9 New England Biolabs

2.9.1 New England Biolabs Details

2.9.2 New England Biolabs Major Business

2.9.3 New England Biolabs Competent Cells Product and Solutions

2.9.4 New England Biolabs Competent Cells Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 New England Biolabs Recent Developments and Future Plans

2.10 QIAGEN N.V.

2.10.1 QIAGEN N.V. Details

2.10.2 QIAGEN N.V. Major Business

2.10.3 QIAGEN N.V. Competent Cells Product and Solutions

2.10.4 QIAGEN N.V. Competent Cells Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 QIAGEN N.V. Recent Developments and Future Plans

2.11 OriGene Technologies

2.11.1 OriGene Technologies Details

2.11.2 OriGene Technologies Major Business

2.11.3 OriGene Technologies Competent Cells Product and Solutions

2.11.4 OriGene Technologies Competent Cells Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11.5 OriGene Technologies Recent Developments and Future Plans

2.12 Lucigen

2.12.1 Lucigen Details

2.12.2 Lucigen Major Business

2.12.3 Lucigen Competent Cells Product and Solutions

2.12.4 Lucigen Competent Cells Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.12.5 Lucigen Recent Developments and Future Plans

2.13 Zymo Research

2.13.1 Zymo Research Details

2.13.2 Zymo Research Major Business

2.13.3 Zymo Research Competent Cells Product and Solutions

2.13.4 Zymo Research Competent Cells Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.13.5 Zymo Research Recent Developments and Future Plans

2.14 Bio-Rad Laboratories

2.14.1 Bio-Rad Laboratories Details

2.14.2 Bio-Rad Laboratories Major Business

2.14.3 Bio-Rad Laboratories Competent Cells Product and Solutions

2.14.4 Bio-Rad Laboratories Competent Cells Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.14.5 Bio-Rad Laboratories Recent Developments and Future Plans

2.15 Bioline

2.15.1 Bioline Details

2.15.2 Bioline Major Business

2.15.3 Bioline Competent Cells Product and Solutions

2.15.4 Bioline Competent Cells Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.15.5 Bioline Recent Developments and Future Plans

2.16 Delphi Genetics

2.16.1 Delphi Genetics Details

2.16.2 Delphi Genetics Major Business

2.16.3 Delphi Genetics Competent Cells Product and Solutions

2.16.4 Delphi Genetics Competent Cells Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.16.5 Delphi Genetics Recent Developments and Future Plans

2.17 IBA GmBH

2.17.1 IBA GmBH Details

2.17.2 IBA GmBH Major Business

2.17.3 IBA GmBH Competent Cells Product and Solutions

2.17.4 IBA GmBH Competent Cells Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.17.5 IBA GmBH Recent Developments and Future Plans

2.18 Cell Applications

2.18.1 Cell Applications Details

2.18.2 Cell Applications Major Business

2.18.3 Cell Applications Competent Cells Product and Solutions

2.18.4 Cell Applications Competent Cells Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.18.5 Cell Applications Recent Developments and Future Plans

2.19 BioDynamics Laboratory

2.19.1 BioDynamics Laboratory Details

2.19.2 BioDynamics Laboratory Major Business

2.19.3 BioDynamics Laboratory Competent Cells Product and Solutions

2.19.4 BioDynamics Laboratory Competent Cells Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.19.5 BioDynamics Laboratory Recent Developments and Future Plans

2.20 Scarab Genomics

2.20.1 Scarab Genomics Details

2.20.2 Scarab Genomics Major Business

2.20.3 Scarab Genomics Competent Cells Product and Solutions

2.20.4 Scarab Genomics Competent Cells Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.20.5 Scarab Genomics Recent Developments and Future Plans

2.21 GCC Biotech

2.21.1 GCC Biotech Details

2.21.2 GCC Biotech Major Business

2.21.3 GCC Biotech Competent Cells Product and Solutions

2.21.4 GCC Biotech Competent Cells Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.21.5 GCC Biotech Recent Developments and Future Plans

2.22 SMOBIO Technology

2.22.1 SMOBIO Technology Details

2.22.2 SMOBIO Technology Major Business

2.22.3 SMOBIO Technology Competent Cells Product and Solutions

2.22.4 SMOBIO Technology Competent Cells Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.22.5 SMOBIO Technology Recent Developments and Future Plans

2.23 Edge BioSystems

2.23.1 Edge BioSystems Details

2.23.2 Edge BioSystems Major Business

2.23.3 Edge BioSystems Competent Cells Product and Solutions

2.23.4 Edge BioSystems Competent Cells Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.23.5 Edge BioSystems Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Competent Cells Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Competent Cells Players Market Share in 2021

3.2.2 Top 10 Competent Cells Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Competent Cells Players Head Office, Products and Services Provided

3.4 Competent Cells Mergers & Acquisitions

3.5 Competent Cells New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Competent Cells Revenue and Market Share by Type (2017-2022)

4.2 Global Competent Cells Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Competent Cells Revenue Market Share by Application (2017-2022)

5.2 Global Competent Cells Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Competent Cells Revenue by Type (2017-2028)

6.2 North America Competent Cells Revenue by Application (2017-2028)

6.3 North America Competent Cells Market Size by Country

6.3.1 North America Competent Cells Revenue by Country (2017-2028)

6.3.2 United States Competent Cells Market Size and Forecast (2017-2028)

6.3.3 Canada Competent Cells Market Size and Forecast (2017-2028)

6.3.4 Mexico Competent Cells Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Competent Cells Revenue by Type (2017-2028)

7.2 Europe Competent Cells Revenue by Application (2017-2028)

7.3 Europe Competent Cells Market Size by Country

7.3.1 Europe Competent Cells Revenue by Country (2017-2028)

7.3.2 Germany Competent Cells Market Size and Forecast (2017-2028)

7.3.3 France Competent Cells Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Competent Cells Market Size and Forecast (2017-2028)

7.3.5 Russia Competent Cells Market Size and Forecast (2017-2028)

7.3.6 Italy Competent Cells Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Competent Cells Revenue by Type (2017-2028)

8.2 Asia-Pacific Competent Cells Revenue by Application (2017-2028)

8.3 Asia-Pacific Competent Cells Market Size by Region

8.3.1 Asia-Pacific Competent Cells Revenue by Region (2017-2028)

8.3.2 China Competent Cells Market Size and Forecast (2017-2028)

8.3.3 Japan Competent Cells Market Size and Forecast (2017-2028)

8.3.4 South Korea Competent Cells Market Size and Forecast (2017-2028)

8.3.5 India Competent Cells Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Competent Cells Market Size and Forecast (2017-2028)

8.3.7 Australia Competent Cells Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Competent Cells Revenue by Type (2017-2028)

9.2 South America Competent Cells Revenue by Application (2017-2028)

9.3 South America Competent Cells Market Size by Country

9.3.1 South America Competent Cells Revenue by Country (2017-2028)

9.3.2 Brazil Competent Cells Market Size and Forecast (2017-2028)

9.3.3 Argentina Competent Cells Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Competent Cells Revenue by Type (2017-2028)

10.2 Middle East & Africa Competent Cells Revenue by Application (2017-2028)

10.3 Middle East & Africa Competent Cells Market Size by Country

10.3.1 Middle East & Africa Competent Cells Revenue by Country (2017-2028)

10.3.2 Turkey Competent Cells Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Competent Cells Market Size and Forecast (2017-2028)

10.3.4 UAE Competent Cells Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Competent Cells Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Competent Cells Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Competent Cells Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Competent Cells Revenue (USD Million) by Region (2017-2022)

Table 5. Global Competent Cells Revenue Market Share by Region (2023-2028)

Table 6. Merck KGaA Corporate Information, Head Office, and Major Competitors

Table 7. Merck KGaA Major Business

Table 8. Merck KGaA Competent Cells Product and Solutions

Table 9. Merck KGaA Competent Cells Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors

Table 11. Thermo Fisher Scientific Major Business

Table 12. Thermo Fisher Scientific Competent Cells Product and Solutions

Table 13. Thermo Fisher Scientific Competent Cells Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Agilent Technologies Corporate Information, Head Office, and Major Competitors

Table 15. Agilent Technologies Major Business

Table 16. Agilent Technologies Competent Cells Product and Solutions

Table 17. Agilent Technologies Competent Cells Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Takara Bio Corporate Information, Head Office, and Major Competitors

Table 19. Takara Bio Major Business

Table 20. Takara Bio Competent Cells Product and Solutions

Table 21. Takara Bio Competent Cells Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Promega Corporation Corporate Information, Head Office, and Major Competitors

Table 23. Promega Corporation Major Business

Table 24. Promega Corporation Competent Cells Product and Solutions

Table 25. Promega Corporation Competent Cells Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Beijing TransGen Biotech Corporate Information, Head Office, and Major Competitors

Table 27. Beijing TransGen Biotech Major Business

Table 28. Beijing TransGen Biotech Competent Cells Product and Solutions

Table 29. Beijing TransGen Biotech Competent Cells Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. GeneScript Corporation Corporate Information, Head Office, and Major Competitors

Table 31. GeneScript Corporation Major Business

Table 32. GeneScript Corporation Competent Cells Product and Solutions

Table 33. GeneScript Corporation Competent Cells Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Yeastern Biotech Corporate Information, Head Office, and Major Competitors

Table 35. Yeastern Biotech Major Business

Table 36. Yeastern Biotech Competent Cells Product and Solutions

Table 37. Yeastern Biotech Competent Cells Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. New England Biolabs Corporate Information, Head Office, and Major Competitors

Table 39. New England Biolabs Major Business

Table 40. New England Biolabs Competent Cells Product and Solutions

Table 41. New England Biolabs Competent Cells Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. QIAGEN N.V. Corporate Information, Head Office, and Major Competitors

Table 43. QIAGEN N.V. Major Business

Table 44. QIAGEN N.V. Competent Cells Product and Solutions

Table 45. QIAGEN N.V. Competent Cells Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. OriGene Technologies Corporate Information, Head Office, and Major Competitors

Table 47. OriGene Technologies Major Business

Table 48. OriGene Technologies Competent Cells Product and Solutions

Table 49. OriGene Technologies Competent Cells Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 50. Lucigen Corporate Information, Head Office, and Major Competitors

Table 51. Lucigen Major Business

Table 52. Lucigen Competent Cells Product and Solutions

Table 53. Lucigen Competent Cells Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 54. Zymo Research Corporate Information, Head Office, and Major Competitors

Table 55. Zymo Research Major Business

Table 56. Zymo Research Competent Cells Product and Solutions

Table 57. Zymo Research Competent Cells Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 58. Bio-Rad Laboratories Corporate Information, Head Office, and Major Competitors

Table 59. Bio-Rad Laboratories Major Business

Table 60. Bio-Rad Laboratories Competent Cells Product and Solutions

Table 61. Bio-Rad Laboratories Competent Cells Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 62. Bioline Corporate Information, Head Office, and Major Competitors

Table 63. Bioline Major Business

Table 64. Bioline Competent Cells Product and Solutions

Table 65. Bioline Competent Cells Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 66. Delphi Genetics Corporate Information, Head Office, and Major Competitors

Table 67. Delphi Genetics Major Business

Table 68. Delphi Genetics Competent Cells Product and Solutions

Table 69. Delphi Genetics Competent Cells Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 70. IBA GmBH Corporate Information, Head Office, and Major Competitors

Table 71. IBA GmBH Major Business

Table 72. IBA GmBH Competent Cells Product and Solutions

Table 73. IBA GmBH Competent Cells Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 74. Cell Applications Corporate Information, Head Office, and Major Competitors

Table 75. Cell Applications Major Business

Table 76. Cell Applications Competent Cells Product and Solutions

Table 77. Cell Applications Competent Cells Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 78. BioDynamics Laboratory Corporate Information, Head Office, and Major Competitors

Table 79. BioDynamics Laboratory Major Business

Table 80. BioDynamics Laboratory Competent Cells Product and Solutions

Table 81. BioDynamics Laboratory Competent Cells Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 82. Scarab Genomics Corporate Information, Head Office, and Major Competitors

Table 83. Scarab Genomics Major Business

Table 84. Scarab Genomics Competent Cells Product and Solutions

Table 85. Scarab Genomics Competent Cells Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 86. GCC Biotech Corporate Information, Head Office, and Major Competitors

Table 87. GCC Biotech Major Business

Table 88. GCC Biotech Competent Cells Product and Solutions

Table 89. GCC Biotech Competent Cells Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 90. SMOBIO Technology Corporate Information, Head Office, and Major Competitors

Table 91. SMOBIO Technology Major Business

Table 92. SMOBIO Technology Competent Cells Product and Solutions

Table 93. SMOBIO Technology Competent Cells Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 94. Edge BioSystems Corporate Information, Head Office, and Major Competitors

Table 95. Edge BioSystems Major Business

Table 96. Edge BioSystems Competent Cells Product and Solutions

Table 97. Edge BioSystems Competent Cells Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 98. Global Competent Cells Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 99. Global Competent Cells Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 100. Breakdown of Competent Cells by Company Type (Tier 1, Tier 2 and Tier 3)

Table 101. Competent Cells Players Head Office, Products and Services Provided

Table 102. Competent Cells Mergers & Acquisitions in the Past Five Years

Table 103. Competent Cells New Entrants and Expansion Plans

Table 104. Global Competent Cells Revenue (USD Million) by Type (2017-2022)

Table 105. Global Competent Cells Revenue Share by Type (2017-2022)

Table 106. Global Competent Cells Revenue Forecast by Type (2023-2028)

Table 107. Global Competent Cells Revenue by Application (2017-2022)

Table 108. Global Competent Cells Revenue Forecast by Application (2023-2028)

Table 109. North America Competent Cells Revenue by Type (2017-2022) & (USD Million)

Table 110. North America Competent Cells Revenue by Type (2023-2028) & (USD Million)

Table 111. North America Competent Cells Revenue by Application (2017-2022) & (USD Million)

Table 112. North America Competent Cells Revenue by Application (2023-2028) & (USD Million)

Table 113. North America Competent Cells Revenue by Country (2017-2022) & (USD Million)

Table 114. North America Competent Cells Revenue by Country (2023-2028) & (USD Million)

Table 115. Europe Competent Cells Revenue by Type (2017-2022) & (USD Million)

Table 116. Europe Competent Cells Revenue by Type (2023-2028) & (USD Million)

Table 117. Europe Competent Cells Revenue by Application (2017-2022) & (USD Million)

Table 118. Europe Competent Cells Revenue by Application (2023-2028) & (USD Million)

Table 119. Europe Competent Cells Revenue by Country (2017-2022) & (USD Million)

Table 120. Europe Competent Cells Revenue by Country (2023-2028) & (USD Million)

Table 121. Asia-Pacific Competent Cells Revenue by Type (2017-2022) & (USD Million)

Table 122. Asia-Pacific Competent Cells Revenue by Type (2023-2028) & (USD Million)

Table 123. Asia-Pacific Competent Cells Revenue by Application (2017-2022) & (USD Million)

Table 124. Asia-Pacific Competent Cells Revenue by Application (2023-2028) & (USD Million)

Table 125. Asia-Pacific Competent Cells Revenue by Region (2017-2022) & (USD Million)

Table 126. Asia-Pacific Competent Cells Revenue by Region (2023-2028) & (USD Million)

Table 127. South America Competent Cells Revenue by Type (2017-2022) & (USD Million)

Table 128. South America Competent Cells Revenue by Type (2023-2028) & (USD Million)

Table 129. South America Competent Cells Revenue by Application (2017-2022) & (USD Million)

Table 130. South America Competent Cells Revenue by Application (2023-2028) & (USD Million)

Table 131. South America Competent Cells Revenue by Country (2017-2022) & (USD Million)

Table 132. South America Competent Cells Revenue by Country (2023-2028) & (USD Million)

Table 133. Middle East & Africa Competent Cells Revenue by Type (2017-2022) & (USD Million)

Table 134. Middle East & Africa Competent Cells Revenue by Type (2023-2028) & (USD Million)

Table 135. Middle East & Africa Competent Cells Revenue by Application (2017-2022) & (USD Million)

Table 136. Middle East & Africa Competent Cells Revenue by Application (2023-2028) & (USD Million)

Table 137. Middle East & Africa Competent Cells Revenue by Country (2017-2022) & (USD Million)

Table 138. Middle East & Africa Competent Cells Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Competent Cells Picture

Figure 2. Global Competent Cells Revenue Market Share by Type in 2021

Figure 3. Chemically Competent Cells

Figure 4. Electrocompetent Cells

Figure 5. Competent Cells Revenue Market Share by Application in 2021

Figure 6. Subcloning & Routine Cloning Picture

Figure 7. Phage Display Library Construction Picture

Figure 8. Toxic/Unstable DNA Cloning Picture

Figure 9. High-Throughput Cloning Picture

Figure 10. Protein Expression Picture

Figure 11. Mutagenesis Picture

Figure 12. Single-Stranded DNA Production Picture

Figure 13. Bacmid Creation Picture

Figure 14. Cre-Lox Recombination (PIR1/PIR2) Picture

Figure 15. Global Competent Cells Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 16. Global Competent Cells Revenue and Forecast (2017-2028) & (USD Million)

Figure 17. Global Competent Cells Revenue Market Share by Region (2017-2028)

Figure 18. Global Competent Cells Revenue Market Share by Region in 2021

Figure 19. North America Competent Cells Revenue (USD Million) and Growth Rate (2017-2028)

Figure 20. Europe Competent Cells Revenue (USD Million) and Growth Rate (2017-2028)

Figure 21. Asia-Pacific Competent Cells Revenue (USD Million) and Growth Rate (2017-2028)

Figure 22. South America Competent Cells Revenue (USD Million) and Growth Rate (2017-2028)

Figure 23. Middle East and Africa Competent Cells Revenue (USD Million) and Growth Rate (2017-2028)

Figure 24. Competent Cells Market Drivers

Figure 25. Competent Cells Market Restraints

Figure 26. Competent Cells Market Trends

Figure 27. Merck KGaA Recent Developments and Future Plans

Figure 28. Thermo Fisher Scientific Recent Developments and Future Plans

Figure 29. Agilent Technologies Recent Developments and Future Plans

Figure 30. Takara Bio Recent Developments and Future Plans

Figure 31. Promega Corporation Recent Developments and Future Plans

Figure 32. Beijing TransGen Biotech Recent Developments and Future Plans

Figure 33. GeneScript Corporation Recent Developments and Future Plans

Figure 34. Yeastern Biotech Recent Developments and Future Plans

Figure 35. New England Biolabs Recent Developments and Future Plans

Figure 36. QIAGEN N.V. Recent Developments and Future Plans

Figure 37. OriGene Technologies Recent Developments and Future Plans

Figure 38. Lucigen Recent Developments and Future Plans

Figure 39. Zymo Research Recent Developments and Future Plans

Figure 40. Bio-Rad Laboratories Recent Developments and Future Plans

Figure 41. Bioline Recent Developments and Future Plans

Figure 42. Delphi Genetics Recent Developments and Future Plans

Figure 43. IBA GmBH Recent Developments and Future Plans

Figure 44. Cell Applications Recent Developments and Future Plans

Figure 45. BioDynamics Laboratory Recent Developments and Future Plans

Figure 46. Scarab Genomics Recent Developments and Future Plans

Figure 47. GCC Biotech Recent Developments and Future Plans

Figure 48. SMOBIO Technology Recent Developments and Future Plans

Figure 49. Edge BioSystems Recent Developments and Future Plans

Figure 50. Global Competent Cells Revenue Share by Players in 2021

Figure 51. Competent Cells Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 52. Global Top 3 Players Competent Cells Revenue Market Share in 2021

Figure 53. Global Top 10 Players Competent Cells Revenue Market Share in 2021

Figure 54. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 55. Global Competent Cells Revenue Share by Type in 2021

Figure 56. Global Competent Cells Market Share Forecast by Type (2023-2028)

Figure 57. Global Competent Cells Revenue Share by Application in 2021

Figure 58. Global Competent Cells Market Share Forecast by Application (2023-2028)

Figure 59. North America Competent Cells Sales Market Share by Type (2017-2028)

Figure 60. North America Competent Cells Sales Market Share by Application (2017-2028)

Figure 61. North America Competent Cells Revenue Market Share by Country (2017-2028)

Figure 62. United States Competent Cells Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. Canada Competent Cells Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. Mexico Competent Cells Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. Europe Competent Cells Sales Market Share by Type (2017-2028)

Figure 66. Europe Competent Cells Sales Market Share by Application (2017-2028)

Figure 67. Europe Competent Cells Revenue Market Share by Country (2017-2028)

Figure 68. Germany Competent Cells Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 69. France Competent Cells Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 70. United Kingdom Competent Cells Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 71. Russia Competent Cells Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 72. Italy Competent Cells Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 73. Asia-Pacific Competent Cells Sales Market Share by Type (2017-2028)

Figure 74. Asia-Pacific Competent Cells Sales Market Share by Application (2017-2028)

Figure 75. Asia-Pacific Competent Cells Revenue Market Share by Region (2017-2028)

Figure 76. China Competent Cells Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 77. Japan Competent Cells Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 78. South Korea Competent Cells Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 79. India Competent Cells Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 80. Southeast Asia Competent Cells Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 81. Australia Competent Cells Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 82. South America Competent Cells Sales Market Share by Type (2017-2028)

Figure 83. South America Competent Cells Sales Market Share by Application (2017-2028)

Figure 84. South America Competent Cells Revenue Market Share by Country (2017-2028)

Figure 85. Brazil Competent Cells Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 86. Argentina Competent Cells Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 87. Middle East and Africa Competent Cells Sales Market Share by Type (2017-2028)

Figure 88. Middle East and Africa Competent Cells Sales Market Share by Application (2017-2028)

Figure 89. Middle East and Africa Competent Cells Revenue Market Share by Country (2017-2028)

Figure 90. Turkey Competent Cells Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 91. Saudi Arabia Competent Cells Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 92. UAE Competent Cells Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 93. Methodology

Figure 94. Research Process and Data Source